Characterization of SARS main protease and inhibitor assay using a fluorogenic substrate (Q44899503)

7 December 2017

title

Characterization of SARS main protease and inhibitor assay using a fluorogenic substrate (English)

1 reference

7 December 2017

0 references

Chih-Jung Kuo

1

1 reference

7 December 2017

Ya-Hui Chi

series ordinal

2

1 reference

7 December 2017

John T-A Hsu

series ordinal

3

1 reference

7 December 2017

Po-Huang Liang

series ordinal

4

1 reference

7 December 2017

language of work or name

English

0 references

publication date

1 June 2004

1 reference

Biochemical and Biophysical Research Communications

7 December 2017

published in

1 reference

7 December 2017

volume

318

1 reference

7 December 2017

issue

4

1 reference

7 December 2017

page(s)

862-867

1 reference

Comparative full-length genome sequence analysis of 14 SARS coronavirus isolates and common mutations associated with putative origins of infection

7 December 2017

cites work

1 reference

https://pubmed.ncbi.nlm.nih.gov/15147951

12 December 2020

A novel coronavirus associated with severe acute respiratory syndrome

1 reference

https://pubmed.ncbi.nlm.nih.gov/15147951

12 December 2020

Characterization of severe acute respiratory syndrome coronavirus genomes in Taiwan: molecular epidemiology and genome evolution

1 reference

https://pubmed.ncbi.nlm.nih.gov/15147951

12 December 2020

Biosynthesis, Purification, and Substrate Specificity of Severe Acute Respiratory Syndrome Coronavirus 3C-like Proteinase

1 reference

https://pubmed.ncbi.nlm.nih.gov/15147951

12 December 2020

Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus

1 reference

https://pubmed.ncbi.nlm.nih.gov/15147951

12 December 2020

Probing the conformational change of Escherichia coli undecaprenyl pyrophosphate synthase during catalysis using an inhibitor and tryptophan mutants

1 reference

https://pubmed.ncbi.nlm.nih.gov/15147951

12 December 2020

Identification of a novel coronavirus in patients with severe acute respiratory syndrome

1 reference

https://pubmed.ncbi.nlm.nih.gov/15147951

12 December 2020

Site-directed mutagenesis probing the catalytic role of arginines 165 and 166 of human cytomegalovirus protease

1 reference

https://pubmed.ncbi.nlm.nih.gov/15147951

12 December 2020

Coronavirus main proteinase (3CLpro) structure: basis for design of anti-SARS drugs

1 reference

https://pubmed.ncbi.nlm.nih.gov/15147951

12 December 2020

Characterization of the monomer-dimer equilibrium of human cytomegalovirus protease by kinetic methods

1 reference

https://pubmed.ncbi.nlm.nih.gov/15147951

12 December 2020

The crystal structures of severe acute respiratory syndrome virus main protease and its complex with an inhibitor

1 reference

https://pubmed.ncbi.nlm.nih.gov/15147951

12 December 2020

Structure of coronavirus main proteinase reveals combination of a chymotrypsin fold with an extra alpha-helical domain

1 reference

https://pubmed.ncbi.nlm.nih.gov/15147951

12 December 2020

Aetiology: Koch's postulates fulfilled for SARS virus

1 reference

https://pubmed.ncbi.nlm.nih.gov/15147951

12 December 2020

Novel fluorogenic substrates for assaying retroviral proteases by resonance energy transfer

1 reference

https://pubmed.ncbi.nlm.nih.gov/15147951

12 December 2020

Characterization of a novel coronavirus associated with severe acute respiratory syndrome

1 reference

https://pubmed.ncbi.nlm.nih.gov/15147951

12 December 2020

Molecular cloning, expression, purification, and mass spectrometric characterization of 3C-like protease of SARS coronavirus

1 reference

https://pubmed.ncbi.nlm.nih.gov/15147951

12 December 2020

Novel peptide inhibitors of angiotensin-converting enzyme 2.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15147951

12 December 2020

Binding mechanism of coronavirus main proteinase with ligands and its implication to drug design against SARS.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15147951

12 December 2020

The Genome sequence of the SARS-associated coronavirus

1 reference

https://pubmed.ncbi.nlm.nih.gov/15147951

12 December 2020

Substrate-based design of the first class of angiotensin-converting enzyme-related carboxypeptidase (ACE2) inhibitors

1 reference

https://pubmed.ncbi.nlm.nih.gov/15147951

12 December 2020

Coronavirus as a possible cause of severe acute respiratory syndrome

1 reference

https://pubmed.ncbi.nlm.nih.gov/15147951

12 December 2020

10.1016/J.BBRC.2004.04.098

Identifiers

DOI

1 reference

7 December 2017

0 references

1 reference